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Introduction: Host genetics is recognized as an influential factor for the development of 
dengue disease.
Objective: This study evaluated the association of dengue with the polymorphisms 
rs8192284 for gene IL6R, rs3775290 for TLR3, and rs7248637 for DC-SIGN.
Materials and methods: Of the 292 surveyed subjects, 191 were confirmed for dengue 
fever and the remaining 101 were included as controls. The genotypes were resolved 
using polymerase chain reaction and restriction fragment length polymorphism (PCR-
RFLP). In an attempt to determine the risk (Odds Ratio) of suffering dengue fever, data 
were analyzed using chi-square for alleles and logistic regression for both genotypes and 
allelic combinations. Confidence intervals were set to 95% for all tests regardless of the 
adjustment by either self-identification or ancestry.
Results: For Afro-Colombians, the allele rs8192284 C offered protection against dengue 
[OR=0.425,(0.204-0.887), p=0.020]. The alleles rs7248637 A and rs3775290 A posed, 
respectively, an increased risk of dengue for Afro-Colombians [OR=2.389, (1.170-4.879), 
p=0.015] and Mestizos [OR=2.329, (1.283-4.226), p=0.005]. The reproducibility for 
rs8192284 C/C [OR=2.45, (1.05-5.76), p=0.013] remained after adjustment by Amerindian 
ancestry [OR=2.52, (1.04-6.09), p=0.013]. The reproducibility for rs3775290 A/A [OR=2.48, 
(1.09-5.65), p=0.033] remained after adjustment by European [OR=2.34, (1.02-5.35), 
p=0.048], Amerindian [OR=2.49, (1.09-5.66), p=0.035], and African ancestry [OR=2.37, 
(1.04-5.41), p=0.046]. Finally, the association of dengue fever with the allelic combination 
CAG [OR=2.07, (1.06-4.05), p=0.033] remained after adjustment by Amerindian ancestry 
[OR=2.16, (1.09-4.28), p=0.028].
Conclusions: Polymorphisms rs8192284 for IL6R, rs3775290 for TLR3, and rs7248637 
for DC-SIGN were associated with the susceptibility to suffer dengue fever in the sampled 
Colombian population.
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Evaluación de las variantes en los genes IL6R, TLR3 y DC-SIGN asociadas con 
dengue en una muestra de población colombiana
Introducción. La genética del huésped se reconoce como un factor que influye en el 
desarrollo del dengue.
Objetivo. Este estudio evaluó la asociación del dengue con los polimorfismos rs8192284 
del gen IL6R, rs3775290 del TLR3 y rs7248637 del DC-SIGN.
Materiales y métodos. De los 292 sujetos encuestados, en 191 se confirmó la presencia 
de fiebre por dengue y los restantes 101 se incluyeron como controles. Los genotipos se 
resolvieron mediante reacción en cadena de la polimerasa y polimorfismos en la longitud 
de los fragmentos de restricción (PCR-RFLP). En un intento por determinar el riesgo de 
sufrir dengue, los datos se analizaron mediante la prueba de ji al cuadrado para los alelos 
y la regresión logística para los genotipos y las combinaciones alélicas. Los intervalos de 
confianza se calcularon a 95 % para todas las pruebas independientemente ajustadas por 
autoidentificación o componente genético ancestral.
Resultados. En los afrocolombianos, el alelo C rs8192284 ofreció protección contra 
el dengue (OR=0,425; 0,204-0,887, p=0,020). Los alelos A rs7248637 y A rs3775290 
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plantearon un mayor riesgo de dengue para los afrocolombianos (OR=2,389; 1,170-
4,879; p=0,015) y los mestizos (OR=2,329; 1,283-4,226: p=0,005), respectivamente. 
La reproducibilidad para rs8192284 C/C (OR=2,45; 1,05-5,76; p=0,013) permaneció 
después del ajuste por el componente genético ancestral amerindio (OR=2,52; 1,04-
6,09; p=0,013). La reproducibilidad del rs3775290 A/A (OR=2,48; 1,09-5,65; p=0,033) 
permaneció después del ajuste por el componente europeo (OR=2,34; 1,02-5,35; 
p=0,048), el amerindio (OR=2,49; 1,09- 5,66; p=0,035), y el africano (OR=2,37; 1,04-
5,41; p=0,046). Por último, la asociación del dengue con la combinación alélica CAG 
(OR=2,07; 1,06-4,05; p=0,033) permaneció después del ajuste por el componente 
genético amerindio (OR=2,16; 1,09-4,28; p=0,028).
Conclusión. Los polimorfismos rs8192284 en IL6R, rs3775290 en TLR3 y rs7248637 en 
DC-SIGN, se asociaron con la propensión a sufrir dengue en una muestra de población 
colombiana. 
Palabras clave: dengue/genética; receptor toll-like 3; polimorfismo genético; Colombia.
Dengue virus (DENV) infection may cause acute systemic diseases. From 
a number of dengue not-licensed vaccines, the one named CYD-TDV has 
been recently approved by the World Health Organization (WHO) (1). The 
CYD-TDV has proven efficacy against confirmed cases in endemic countries 
of the Americas such as Brazil and México (2) but DENV continues to spread 
(3,4) widely in Colombia (5). From the 50 to 100 million infection cases 
estimated worldwide annually (6), roughly 1.5 million occur in Colombia (3). 
Dengue can adopt three clinical forms: Self-limited dengue fever (DF), 
dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS). 
Patients diagnosed with DF present with high fever for two to seven days 
accompanied by at least two mild hemorrhagic manifestations such as 
gingival bleeding, petechiae and the like (6), and/or pain (headache, 
retro-orbital pain, myalgia, or arthralgia, among others). DHF comprises 
very high fever, hemorrhagic trends, hepatomegaly, or extravasation 
(thrombocytopenia and/or pleural effusion). Finally, DSS produces a 
homeostatic alteration characterized by an undetectable pulse before 
death in DHF/DSS (6-8).
DENV infection has a specific set of mechanisms. Dendritic cells are 
the first population DENV attaches to (9). DENV binds to the dendritic 
cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-
SIGN) thanks to the E protein on the DENV surface. There is substantial 
evidence that DC-SIGN is involved with dengue disease development 
(10,11). Upon DENV infection, pro-inflammatory cytokines that are produced 
via DC-SIGN may cause apoptosis when patients display cross-reactivity 
between both platelets and viral antigens (12-15). Some of these cytokines 
are interleukin-6 and interleukin-8. Interleukin-6 triggers inflammation and 
activates a wide range of different cells (16). According to Marín, et al., (17) 
interleukin-6 also induces pro-inflammatory molecules like the interleukin-6-
receptor (IL6R) and its soluble isoform (sIL6R). This receptor is expressed by 
neutrophils and CD4 T-cells (16).
The intercellular mechanisms of DENV infection show patterns associated 
with pathogens that foster its development and propagation. The intracellular 
domain of DC-SIGN drives signaling activation of toll-like receptors (TLR), 
which allow identification of molecular patterns associated with pathogens 
(9). TLRs activate protection mechanisms and mediate the onset of innate 
immune effectors (18). 
The activation of the toll-like receptor 3 (TLR3) inhibits DENV replication in 
monocytes in vitro resulting in antiviral potential through interferons (18,19). 
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Although this activation follows direct binding between TLR3 and intermediate 
double-stranded RNA (dsRNA) from DENV, the conformation of this 
intermediate dsRNA is essential for DENV replication (7). The latter explains, 
to some extent, why expression levels of TLR3 among dengue patients are 
higher than in healthy ones (18).
DC-SIGN is on the nineteenth chromosome in a region of complex 
alternative splicing sites that generate soluble, membrane-associated, and 
truncated isoforms (9). Many variants of DC-SIGN have been evaluated for 
their association with dengue (20) with positive results for some variants 
within the gene (21). For instance, the SNP rs4804803, allele G, and 
genotype G/G are highly conspicuous allelic variants found in studies of 
dengue for the SNP of the rs735239, rs4804803, and rs2287886 located in 
the DC-SIGN promotor (9). In addition, the haplotype AAG is comprised by 
the SNPs rs735239-rs4804803-rs2287886 in synteny (9). However, these 
SNPs are not considered allelic combinations as they are located in the 
same chromosome.
TLR3 is on the fourth chromosome and encodes the TLR3 protein, a 
major effector of immune responses to viral pathogens (18,22). TLR3 is 
found on the surface of the endoplasmic reticulum, endosomes, lysosomes, 
and endolysosomes (23). The role assessment of TLR3 variants in dengue 
physiopathology found that the T of SNP rs3775291 is involved not only in 
disease development but also in its severity (24). Indeed, the frequency of 
this variant was significantly lower among confirmed DHF cases than healthy 
controls in India. The polymorphism rs3775291 affects the protein structure 
and its frequency amounts to 30% between populations with European 
and Asian ancestry, but not in Africans (25). The 412Phe allele reduced the 
activation rate in several diseases, such as myocarditis and nasopharyngeal 
carcinomas, in response to viral infection (22).
The IL6R gene is on the first chromosome and encodes the IL6R/sIL6R 
isoforms. The sIL6R is produced by alternative splicing at the first exon, 
right on the rs8192284 variant and by proteolysis of membrane IL6R with 
the protease ADAM17 (26). ADAM17 recognizes the substitution Asp358Ala 
rs8192284 C, formerly named rs2228145 (27). The sIL6R is a multifunctional 
cytokine essential for the immune response, hematopoiesis, and acute phase 
reactions. It acts via a heterodimeric receptor of proteins. The expression 
of interleukin-6 is triggered 100-1,000 times when linked with both IL6R 
and glycoprotein 130 on the membrane (28). The expression of gp130 is a 
phenomenon known as interleukin-6 trans-signaling. High levels of sIL6R 
have been observed in HIV-positive patients vs healthy controls (29).
The genetic variants IL6R, TLR3, and DC-SIGN could actually be used as 
markers for both susceptibility and prognosis of dengue (20-22,24-27,30). In 
a context of ancestry mixture, determining the association of these variants 
with dengue in the Colombian population is non-existent. However, the risk 
of dengue could be modulated by these variants depending on the ancestry 
context for specific ethnic groups (31). In this context, our study aimed at 
establishing the extent to which dengue associated with the genetic variants 
considered here. To the best of our knowledge, ancestry has not been 
yet considered in the association between dengue and genetic variants in 
Colombia. This study evaluated these associations in a sample of Colombian 
population and the variants in three polymorphisms from three genes of 
immune sensors.
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Materials and methods
Study samples and diagnosis of dengue infection
In an attempt to collect genetically diverse samples, 292 subjects 
were selected from patients at healthcare institutions from two Colombian 
departments: Antioquia and Chocó (figure 1). As a matter of fact, these subjects 
guaranteed varying ancestry in these two locations (31,32). All subjects were 
over 15 years old and recruited during several dengue outbreaks between July, 
2009, and December, 2012. Peripheral blood samples (5 ml) were taken after 
getting the informed consent from all subjects. 
Figure 1. Location of the ten healthcare institutions where subjects were recruited
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The study protocol was approved by the ethics committee at Universidad 
de Antioquia in June, 2009 (code number 09-12-225). The serum samples 
were readily centrifuged and kept in frozen storage (-70°C) prior to analysis. 
The subjects were split into two groups: Controls and cases hinging upon 
confirmation of dengue as proposed by WHO (6,8). The control group was 
comprised of 101 subjects without prior records of dengue. Additionally, all 
subjects in the control group tested negative in the ELISA IgM specific for DENV.
DENV infection in the 191 subjects comprising the case group 
was confirmed through at least one out of three tests: Enzyme-linked 
immunosorbent assays ELISA IgM, IgM seroconversion, or reverse 
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transcription polymerase chain reaction (RT-PCR) (table 1). These techniques 
are detailed by WHO (1997, 2009) (6,8). In short, DENV infection was 
positively confirmed in 157 samples by the specific IgM antibodies (ELISA 
Dengue IgM Panbio, Sinnamon Park, Australia) during its acute phase. 
Sampling was then repeated 15 days later during the convalescent phase, 
and IgM seroconversion was detected in 30 subjects. Five subjects were not 
sampled during the convalescent phase. 
Table 1. Diagnosis and demographics of the subjects
1 These blood samples were taken during the acute phase of dengue. Two hundred and ninety two aliquots of 
blood (one from each participant) were used for DNA extraction, then DNA was destined for variants typing in 
candidate genes, and ancestry-informative markers.
Parameter Detail Count Percentage
ELISA IgM11
IgM seroconversion
RT-PCR
Self-identification
Gender
Age
Positive
Negative
Positive
Positive
Mestizo
Afro-Colombian
Male
Female
Average ± SD
157
101
30
4
162
130
142
150
25±15.8
53.8
34.5
10.2
1.5
55.3
44.7
48.5
51.5
-
Finally, four more cases were confirmed by testing DENV infection in 45 
subjects following the protocol defined by Lanciotti, et al. (1992) as adapted 
by Harris, et al. (1998) and modified by Restrepo, et al., (2012) (33-35). The 
evolution of the symptoms in these latter subjects was of less than five days. 
None of the subjects suffered from malaria (thick drop smear). Self-identification 
served for classifying the subjects as Afro-Colombians or Mestizos.
DNA was isolated from the blood samples following a standard phenol-
chloroform protocol (36). Specific genomic regions were amplified through PCR 
using primers. The ancestry-informative markers (AIMs), its deltas, i.e., allele 
frequencies reported for ancestral populations, and meticulous typing conditions 
that were used in this study have been previously detailed (31). The 30 selected 
AIMs displayed the highest deltas, which in turn were assessed pairwise among 
the three ancestral populations (European, Amerindian, and African) (37). The 
distribution of those AIMs throughout the genome is certainly wide.
Most of these AIMs in the battery of polymorphisms of insertion/
deletion and restriction fragment length (RFLP) were resolved 
using an ABI Prism® 310 Genetic Analyzer (Perkin Elmer-Applied 
Biosystems). Then, we used two primers per variant in each 
candidate gene: forward 5’-AGCTTGTCAAATGGCCTGTTG-3’ 
and reverse 5’-CAGAACAATGGCAATGCAGAG-3’ for 
IL6R, forward 5’-GGAGCATCAGTCGTTGAAG-3’ and 
reverse 5’-CTCAACCTAACCAAGAATAA-3’ for TLR3, and 
forward 5’-AGCCAAAGCTCCTCTAGATC-3’ and reverse 
5’-CAGATGGGGTTTCTCCGTGTT-3’ for DC-SIGN. One enzymatic test was 
performed for resolving one variant in each candidate gene. Specifically, 
HindIII for rs8192284 A/C”, TaqI for rs3775290 G”/A, and Hpy166II for 
rs7248637 G”/A (quotes indicate the cut allele). The resulting fragments were 
then in base pairs: 88, 182; 145, 84; and 138, 88, respectively.
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Analysis
First, the data on sex and age were respectively compared through 
chi-square and Mann-Whitney tests casting case and control groups in 2 x 
2 matrixes. Then, three comparative case-control studies were conducted 
on the 292 subjects using alleles, genotypes, and allelic combinations as 
independent variables. The proportion of alleles was compared between 
groups using chi-square after direct counting. 
Associations both of genotypes and allelic combinations were estimated 
by logistic regression using the SNP stat package (38); p-values <0.05 were 
considered significant and only the lowest were reported. Probability values 
(p-value), odds ratios (OR), and confidence intervals (CI) were adjusted using 
the individual African, Amerindian, and European ancestries as co-variables in 
independent regressions. 
Individual ancestry from AIMs data was estimated using the Admixmap 
program (39). The genotypes were modeled according to inheritance 
(codominant, dominant, recessive, and overdominant). Genotype deviations 
from Hardy-Weinberg equilibrium were calculated using SNPstat package. 
This study focused on developing a model of fixed effects.
Results
Subject diagnosis and demographics
A positive diagnosis for dengue was confirmed in 65.5% (191) of the 
subjects using the three tests, IgM antibody (157), IgM seroconversion (30), 
and RT-PCR (4) between the acute and convalescent phase (table 1). RT-
PCR was performed for 45 subjects, and four tested positive. The serotypes 
DENV-1, -2, and -3 were identified within these four subjects and were 
found to be in complete agreement with those found in official reports from 
2008-2009. For the location, the samples were collected according to the 
procedures established by Restrepo in official reports from 2008-2009 of the 
Instituto Nacional de Salud (personal communication). 
Samples were taken at different times and this could be the reason for 
the low occurrence of viral infections (9%). For subjects tested with RT-PCR, 
samples were often collected after more than four days of symptoms evolution 
during the acute phase of dengue. This is a phase in which viremia starts 
diminishing, making detection of the viral genome rather complex (40). The 
male-female ratio was 48.5% and 51.5%, which suggests a non-significant 
difference. The Mestizo was the most common ethnic group and showed 
differential ancestry proportions when compared with Afro-Colombians. Mestizos 
displayed a high proportion of European ancestry (0.679±0.119) with low levels 
of Amerindian (0.176±0.069) and African (0.154±0.117) ancestries. Among Afro-
Colombians, the proportion of African ancestry was relatively high (0.733±0.219), 
but low for the European (0.178±0.168) and the Amerindian (0.089±0.100).
Allelic variants association with dengue
Every minor allelic frequency was >1% (table 2). Stratification analysis 
revealed that three allelic variants associated significantly with dengue, two in 
Afro-Colombians and one in Mestizos (table 3).These associations posed one 
protective factor and another one for risk of dengue in Afro-Colombians while 
only one single risk factor for Mestizos. In Afro-Colombians, the C allele of 
IL6R rs8192284 presented a lower risk, while a higher risk was present in the 
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Table 2. Allelic frequencies and Hardy-Weinberg equilibrium for all subjects and after stratification by self-identification
Table 3. Allelic variants association with dengue. Columns display associations for all subjects after stratification by self-identification.
SNP: Single nucleotide polymorphism
rs: Reference sequence
 MAF: Minor allele frequency
* MAF is displayed for each ancestral population as reported by NCBI.
SNP: Single nucleotide polymorphism
 rs: Reference sequence
 OR: Odds ratio in chi-square test
CI: Confidence interval; significant p values are in bold.
A allele of DC-SIGN rs7248637. The A allele of TLR3 rs3775290 displayed 
the most significant association with the risk of dengue for Mestizos. No 
significant difference was observed between the allelic frequencies in 
subjects. The data loss rate was minimal.
Genotypic variants association with dengue
The risk of dengue for specific ancestry contexts was studied by identifying 
genotypic variants association with dengue. The three loci remained in 
Hardy-Weinberg equilibrium in all subjects. The frequency of the genotype 
A/A in TLR3 was higher in cases than in controls, either with or without 
ancestry adjustment. The frequency of the genotype C/C in IL6R was also 
higher in cases than in controls, but only when adjusted by the Amerindian 
component and with no adjustment (table 4). No significant association of 
rs7248637 genotypes for cases and controls was found. Eight associations 
with genotypes were found between cases and controls in all subjects.
SNP MAF n=292
Self-identification Continental ancestral population*
Afro-Colombian n=130 Mestizo n=162 European Amerindian African
IL6R rs81922842 
n=292
TLR3 
rs37752902 
n=291
CD209 
rs72486372     
n=281
C
A
A
0.405
0.314
0.169
0.201
0.274
0.247
0.479
0.390
0.119
0.354
0.217
0.129
0.500
0.408
0.110
0.062
0.102
0.358
SNP Allele
All subjects
n=292
Afro-Colombian
n=130
Mestizo
n=162
Cases Controls Cases Controls Cases Controls
IL6R rs8192284
n=292
OR (95% CI)
p value
TLR3 rs3775290
n=291
OR (95% CI)
p value
DC-SIGN 
rs7248637
n=281
OR (95% CI)
p value
C
A
A
0.38
0.39
0.15
0,32
0.30
0.16
0.13
0.28
0.28
0,26
0.31
0.14
0.51
0.45
0.10
0,41
0.26
0.18
1.302 (0.7271-2.333)
0.3737
0.4253 (0.2040-0.8865)
0.0203
1.498 (0.8562-2.620)
0.1560
1.492 (0.8294-2.683)
0.1807
0.8656 (0.4710-1.591)
0.6418 
2.329 (1.283-4.226)
0.0050 
0.9265 (0.4305-1.994)
0.8451
2.389 (1.170-4.879)
0.0151
0.5062 (0.2209-1.160)
0.1030
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SNP IL6R rs8192284
Controls
n=105
Cases
n=187
Without 
adjustment
Adjusted 
European
Adjusted 
Amerindian
Adjusted African
n (%) n (%) OR (95% CI)4 OR (95% CI) OR (95% CI) OR (95% CI)
A/A
A/C
C/C
p-value
47 (44.8)
50 (47.6)
8 (7.6)
79 (42.2)
75 (40.1)
33 (17.6)
1
0.87 (0.53-1.45)
2.45 (1.05-5.76)
0.013
1
0.75 (0.43-1.31)
1.97 (0.81-4.83)
0.032
1
0.91 (0.54-1.54)
2.52 (1.04-6.09)
0.013
1
0.77 (0.44-1.34)
2.00 (0.81-4.97)
0.03
SNP TLR3 rs37752902
Controls
n=105
Cases
n=186
Without 
adjustment
Adjusted 
European
Adjusted 
Amerindian
Adjusted African
n (%) n (%) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
G/G
G/A
A/A
51 (48.6)
45 (42.9)
9 (8.6)
73 (39.2)
81 (43.5)
32 (17.2)
1
1.23 (0.74-2.05)
2.48 (1.09-5.65)
1
1.20 (0.72-2.01)
2.34 (1.02-5.35)
1
1.26 (0.75-2.09)
2.49 (1.09-5.66)
1
1.22 (0.73-2.04)
2.37 (1.04-5.41)
p-value 0.033 0.048 0.035 0.046
R2 del modelo = 0,55 F(2,213) = 133; p <0,001
SNP DC-SIGN rs7248637
Controls
n=103
Cases
n=178
Without 
adjustment
Adjusted 
European
Adjusted 
Amerindian
Adjusted African
n (%) n (%) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
G/G
G/A
A/A
73 (70.9)
28 (27.2)
2 (1.9)
129 (72.5)
43 (24.2)
6 (3.4)
1
0.87 (0.50-1.52)
1.70 (0.33-8.63)
1
0.93 (0.53-1.64)
1.87 (0.36-9.61)
1
0.86 (0.49-1.52)
1.68 (0.33-8.53)
1
0.93 (0.53-1.65)
1.83 (0.36-9.41)
p-value 0.48 0.41 0.48 0.43
Table 4. Association of genotypic variants with dengue for all subjects and after ancestry adjustment
Table 5. Association of allelic combinations with dengue for all subjects and after ancestry adjustment
SNP: Single nucleotide polymorphism
rs: Reference sequence
OR: Odds ratio in chi-square test
CI: Confidence interval. Significant p values are in bold.
* The order of nucleotides in the allelic combinations is based on the order of polymorphisms in the chromosomes rs8192284 - rs3775290 - rs7248637. 
OR: Odds ratio in chi-square test
CI: Confidence interval; significant p values are in bold.
Genotype
Genotype
Genotype
Allelic 
combination*
Controls 
n=191
Cases
n=101
No adjustment
OR (95% CI)
p value
Adjusted European 
OR (95% CI) 
p value
Adjusted Amerindian
OR (95% CI) 
p value
Adjusted African
OR (95% CI)
p value
AGG
AAG
CGG
CAG
AGA
CGA
AAA
CAA
0.4283
0.1555
0.1465
0.1146
0.0688
0.0552
0.031
0
0.2977
0.2085
0.1923
0.1476
0.0986
0.0216
0.0176
0.0162
1
1.68 (0.92-3.07) 0.091
1.60 (0.81-3.18) 0.18
2.07 (1.06-4.05) 0.033
1.96 (0.77-4.97) 0.16
0.59 (0.15-2.26) 0.44
0.92 (0.24-3.56) 0.90
4.48 (0.03-766.15) 0.57
1
1.64 (0.90-2.99) 0.10
1.45 (0.73-2.89) 0.29
1.93 (0.97-3.84) 0.062
2.13 (0.81-5.63) 0.13
0.52 (0.13-2.04) 0.35
0.93 (0.24-3.58) 0.92
4.04 (0.03-523.26) 0.6
1
1.68 (0.92-3.06) 0.092
1.64 (0.81-3.29) 0.17
2.16 (1.09-4.28) 0.028
1.93 (0.76-4.91) 0.17
0.59 (0.15-2.26) 0.44
0.89 (0.23-3.47) 0.87
4.47 (0.03-725.22) 0.6
1
1.65 (0.91-3.00) 0.099
1.46 (0.73-2.92) 0.28
1.96 (0.98-3.91) 0.057
2.09 (0.80-5.45) 0.13
0.54 (0.14-2.09 )0.37
0.95 (0.25-3.64) 0.93
3.92 (0.03-448.76) 0.6
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Variants of allelic combinations associated with dengue
Two associations between dengue and the allelic combination CAG were 
observed (table 5). This association was significant for the Amerindian context 
with and without ancestry adjustment. The CAG combination displayed higher 
frequency in cases than in controls. No significant association between allelic 
combinations and dengue was found after adjusting for either European or 
African ancestries.
Discussion
This study established associations of genetic variants in IL6R, TLR3, 
and DC-SIGN with dengue after using ancestry or auto-identification control 
techniques. To the best of our knowledge, this is the first study in America 
that evaluates the association between dengue and three SNP, namely, 
rs8192284, rs3775290, and rs7248637, which are located in the encoding 
genes IL6R, TLR3, and DC-SIGN, respectively. These encoding genes are 
sensors of the immune system for dengue. The hypothesis evaluated the 
association of the genetic variants with the susceptibility to suffer dengue in 
different Colombian ethnic groups or ancestries. To prove this hypothesis, a 
confirmed dengue group was contrasted using the infection diagnosis in a 
case-control study of sampled Colombian population (table 1).
We determined African, European, and Amerindian ancestries against 
Afro-Colombian and Mestizos. The ancestral genetic context differences 
may influence dengue (41,42). In fact, results of this study concur well with 
Silva (2010) and Galanter (2012) (32,41) by confirming that specific genetic 
variants may act as markers for risk susceptibility of getting dengue in 
different ethnic groups or ancestries as shown in previous studies (10,24).
A total of 191 samples of dengue associated strongly with the genetic 
variants in SNP rs8192284analyzed for IL6R, SNP rs3775290 for TLR3, and 
SNP rs7248637 for DC-SIGN (tables 3, 4, and 5). Thus, the effect of the three 
SNPs on the physiopathology should be strong, since this genetic association 
was found within a small sample. Evidently, the polymorphisms regulate 
transcription for both receptors and other genes of the immune system 
that participate in viral recognition and interferon gamma production as a 
response to DENV infection (19). Additionally, the risk allele combination for 
dengue CAG found in IL6R/TLR3/DC-SIGN (table 3) was significant without 
ancestry adjustment and also when controlling for the Amerindian component 
(p<0.05). A similar trend was found when controlling for both European and 
African components, although it was not statistically significant. The single 
most marked observation to emerge from the analysis of allelic combinations 
was acknowledging the interdependence of all polymorphisms (43).
From the point of view of the analyses for alleles and genotypes, variants 
associated repeatedly with dengue. A comparison between Afro-Colombian 
and Mestizo ancestry groups showed that the proportion of the allele C was 
significantly different (p<0.05) in cases and controls (table 3). The dengue 
associated with SNP rs8192284 when the genotype C/C was considered 
before and after controlling for Amerindian ancestry. These repeated 
associations between variants and dengue could be explained by the likely 
participation of SNP rs8192284 in the development of joint pain during 
the acute phase of a number of diseases (6). Additionally, these variants 
contribute to inflammation amplification among dengue patients via sIL-6/mIL-
6 as reported for SNP rs8192284 in other pathologies (26).
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The association between dengue and the variants of SNP rs8192284 for 
IL6R has not yet been fully established. Notwithstanding, the strong role of 
the encoding IL6R in the evolution of other diseases like HIV-I as regards viral 
aetiology has been widely addressed (29). In fact, the evidence on the role of 
the allele C in increasing inflammation for a number of diseases is compelling. 
For example, allele C strengthens the development of serious illnesses such 
as arthritis and myeloma (44,45).
The genetic determination of rs8192284 is explained by the enhanced 
transcription of dendritic cells up to more than 1000 fold for the IL-6. Also, the 
proteolytic receptor binds to the membrane (mIL-6) just in the alanine 358 that 
is encoded by the allele C and linked to interleukine-6 (28). The association 
between the variants in genes IL-6, TNFA, INFG and the interleukine-6 levels 
found in dengue cases has been previously established in Colombia (46). 
Through linkage disequilibrium, the SNP rs8192284 has also displayed synteny 
of rs4537545 with other variants in genes IL6/IL6R/pg130in a Caucasian 
Italian population (47). Naturally, the variants in gene IL-6 weigh the severity 
of DHF(46). On the other hand, the inflammatory signal from dendritic cells is 
amplified by the soluble form of the receptor (sIL6-R), which results in remote 
activation of synoviocytes, chondrocytes, and a number of organs (16,48,49).
With regards to SNP rs3775290 for TLR3, the allele A, genotype A/A, and 
allelic combination CAG were significantly different between cases and controls 
(p<0.05). As reported by Alagarasu, et al., (24) the evidence we found confirms 
the contribution of TLR3 polymorphisms to the development of dengue disease 
for populations in admixture like the Indian. From the point of view of the 
variability in those allelic variants, it would appear that there are factors for both 
risk of and protection against developing dengue (table 3). Several authors have 
challenged this view on the grounds that these factors could change depending 
on the context of genetic admixture for the ethnic groups to be compared 
(31,41,42). However, as put forward by Zapata, et al., (12), the variability in 
alleles, genotypes, and allelic combinations could be explained by specific 
differences in the immune response displayed by different ethnic groups. This 
is consistent with the differences in susceptibility to dengue found between 
ethnic groups in South America (41). Our results for genotypic distributions and 
allelic combinations have a number of similarities with these authors (tables 
3 and 4). An increasing number of studies have recently found evidence that 
the SNPrs3775290 is strongly associated with virus-related diseases for ethnic 
groups with a high proportion of either European or African ancestry (50,51).
The role of SNP rs3775290 in viral aetiology has received much attention in 
the last few years (52). For example, interferon-stimulated response elements 
were found whilst studying the promoter sequence of TLR3 in silico (30). There 
is evidence to support the hypothesis that this promoter affects the response of 
TLR3 and other proinflammatory cytokines. The synergy of the proinflammatory 
cytokines with TNFA and INFG results in enhanced TLRs production (30). The 
TLR3 abundance in endosomes of both dendritic and T cells during dengue 
development is essential for the immune system to counteract the viral infection 
(23). In addition, the synonym change F459F encoded by SNP rs3775290 is 
in strong linkage disequilibrium with rs3775291 among Chinese and Polish 
population (30,51). In both cases, the disease was triggered by a viral infection 
(HCMV) with severe implications for its development. Evidence of the linkage 
between rs3775290 and other functional variants that code no synonym 
changes in TLR3 for Colombian population is lacking. Further research needs 
to be carried out to establish whether rs3775290 is in synteny with rs3775291.
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As regards DC-SIGN, it plays a major role in sensing the viral infection 
and mediating pathogenesis control (22). The SNP rs7248637 is important 
owing to its influence on the DC-SIGN transcription. The SNP rs7248637 lies 
in the 3’-untranslated region of the DC-SIGN that happens to determine the 
transcript half-life (53). The development of other viral infections is often rapid 
when transcript levels decrease due to escape to the immune system (53). 
The SNP rs7248637 is also involved in the regulation and recognition of a 
micro-ARN of interference (miARN) (53), which is capable of modulating the 
risk against getting a disease in response to viral infections for the African 
population. As anticipated, our results show that rs7248637 greatly relates to 
dengue development due to its functional effects.
Worldwide, dengue conspicuously associates with a number of variants for 
DC-SIGN (10,21) because of the aforementioned mechanisms. The association 
of those variants for DC-SIGN with dengue is more assertively controlled by 
ancestry than by self-identification (31,42). DC-SIGN supports a variety of primary 
immune responses. Furthermore, other variants for DC-SIGN could decrease the 
platelet adhesion that leads to thrombocytopenia (9). DENV infection promotes 
the destruction of both platelets and megakaryocytes in vitro (12). It is thus highly 
likely that DENV infection impairs homeostasis regulation in vivo.
This study has given an account of the association between dengue 
and the variants in SNPs rs8192284 for IL6R, rs3775290 for TLR3, and 
rs7248637 for DC-SIGN. This means that the genetic component that affects 
the variability in dengue progression is partially comprised by the variants for 
the genes IL6R, TLR3, and DC-SIGN. Considerable insight has been gained 
into genetic markers for dengue prediction, for example, therapeutic targets.
Further work could evaluate the role of other variants in the antiviral 
response associated with IFNs production through TLR3 (4). Zapata, et 
al., (12) have shown that enhanced production of interferon gamma favors 
the increase in megakaryocytes that take part in the possible development 
of dengue coagulopathies. Additional work may look at the association of 
dengue with all the variants from the polymorphisms in the entire TLRs family, 
especially with TLRs3/4/7/9. More functional studies are also needed to 
establish the role of each TLR in the physiopathology and severity of dengue 
in admixed populations such as the Colombian one.
Our findings may have a number of medical applications. One could be 
preventing dengue disease in African, European and Amerindian ancestry 
contexts or ethnic groups by looking at SNP frequencies associated with 
the risk of getting dengue, which can be assessed through the count of risk 
alleles in populations or individuals. This knowledge could lead to designing 
strategies based on non-genetic risk factors such as the use of bed nets 
and mosquito population control. A second application could be long-term 
evaluations of associations between the IL6R, TLR3, and DC-SIGN variants 
and other phenotypes related to DENV infection, such as the progression of 
hemorrhagic dengue, plasmatic extravasation, and cytokines production by 
genic expression assays, as well as other functional molecular studies. 
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